Table 3.
Follow-up characteristics (n = 120).
| Group 1 (n = 60) | Group 2 (control, n = 60) | P-value | |
|---|---|---|---|
| Free of arrhythmia after index procedure, n (%) | 19 (31.7%) | 24 (40.0%) | 0.34 |
| Free of arrhythmia and off-AAD after index procedure, n (%) | 9 (15%) | 18 (30%) | 0.08 |
| Free of arrhythmia after one repeat procedure, n (%) | 48 (80.0%) | 52 (86.7%) | 0.46 |
| Free of arrhythmia at end of follow-up, n (%) | 54 (90.0%) | 57 (95.0%) | 0.49 |
| Out of AAD after last procedure, n (%) | 28 (46.6%) | 33 (55.0%) | 0.46 |
| Without any recurrence, n (%) | 9 (32.1%) | 18 (54.5%) | 0.22 |
| Number of procedures per patient, median (Q1–Q3) | 2 (2–2) | 2 (2-2) | 0.11 |
| Atrial tachyarrhythmias recurrence, n (%) | 41 (68.3%) | 36 (60.0%) | 0.45 |
| Atrial fibrillation, n (%) | 19 (46.0%) | 28 (78.0%) | 0.09 |
| Atrial tachycardia | 22 (54.0%) | 8 (22.0%) | 0.03 |
| Time to first recurrence, median (Q1–Q3), n (%) | 13 (9–17) | 19 (8–22) | 0.06 |
| Major complication | 0 | 0 | 0.91 |
AAD, Antiarrhythmic drugs.